Aastha Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aastha Gupta has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Ankur Sood
School of Chemical Sciences and Advanced Materials Research Centre Indian Institute of Technology Mandi Mandi Himachal Pradesh 175075 India
1 shared publicationDimpy Bhardwaj
School of Chemical Sciences and Advanced Materials Research Centre Indian Institute of Technology Mandi Mandi Himachal Pradesh 175075 India
1 shared publication- Garima Agrawal
School of Chemical Sciences and Advanced Materials Research Centre, Indian Institute of Technology Mandi, Mandi, India
1 shared publication Nishith Shrimali
Disease Biology Laboratory Regional Centre for Biotechnology National Capital Region Biotech Science Cluster Faridabad Haryana 121001 India
1 shared publicationPrasenjit Guchhait
Disease Biology Laboratory Regional Centre for Biotechnology National Capital Region Biotech Science Cluster Faridabad Haryana 121001 India
1 shared publicationRitu Singhmar
School of Chemical Sciences and Advanced Materials Research Centre Indian Institute of Technology Mandi Mandi Himachal Pradesh 175075 India
1 shared publication
Latest Publications
- 1 November 2023
- Published by Wiley in Advanced Therapeutics
- Vol. 7 (2)
Functionalized Chitosan Decorated Hafnium Oxide@Gold Core–Shell Nanoparticles for Multimodal Cancer Therapy
Herein, the fabrication of chitosan stabilized multifunctional hafnium oxide@gold core–shell nanoparticles (HAT NPs) (≈12 nm) is described. The developed nanoparticulate system offers multimodal action by providing stimuli responsive anticancer drug delivery along with imparting radiosensitization to cancer cells, thereby protecting surrounding normal tissues from damage. HAT NPs exhibit good capability of loading doxorubicin (DOX), an anticancer drug with ≈87% encapsulation efficiency. DOX loaded HAT NPs are able to release ≈91% DOX under GSH reducing conditions, that is a representative of the cancer cell microenvironment. The cytotoxicity of the developed DOX loaded HAT NPs is tested against breast cancer cells (MDA‐MB‐231) showing higher cytotoxicity as compared to free DOX. In addition, the ability of HAT NPs to generate ROS activity upon irradiation by gamma radiations (0.5 & 5 Gy) is also analyzed in cancer cells to demonstrate the ability of synthesized system as a potent candidate to present radio sensitization. Further, in vivo biodistribution studies are executed to understand the tissue specific retention of HAT NPs for their future utility in targeted cancer treatment applications.
- 1 November 2023
- Published by Wiley in Advanced Therapeutics
- Vol. 7 (2)
Functionalized Chitosan Decorated Hafnium Oxide@Gold Core–Shell Nanoparticles for Multimodal Cancer Therapy
Herein, the fabrication of chitosan stabilized multifunctional hafnium oxide@gold core–shell nanoparticles (HAT NPs) (≈12 nm) is described. The developed nanoparticulate system offers multimodal action by providing stimuli responsive anticancer drug delivery along with imparting radiosensitization to cancer cells, thereby protecting surrounding normal tissues from damage. HAT NPs exhibit good capability of loading doxorubicin (DOX), an anticancer drug with ≈87% encapsulation efficiency. DOX loaded HAT NPs are able to release ≈91% DOX under GSH reducing conditions, that is a representative of the cancer cell microenvironment. The cytotoxicity of the developed DOX loaded HAT NPs is tested against breast cancer cells (MDA‐MB‐231) showing higher cytotoxicity as compared to free DOX. In addition, the ability of HAT NPs to generate ROS activity upon irradiation by gamma radiations (0.5 & 5 Gy) is also analyzed in cancer cells to demonstrate the ability of synthesized system as a potent candidate to present radio sensitization. Further, in vivo biodistribution studies are executed to understand the tissue specific retention of HAT NPs for their future utility in targeted cancer treatment applications.